Company name:Alliance Pharma
EPIC:APHTrading Currency:GBX
Market Sector:ASM6ISIN:GB0031030819
Market Segment:AMSMShare Type:DE
WWW Address:Description:ORD 1P
 Price Price Change [%] Bid Ask Open High Low Volume
 48.50 -1.0 [-2.02] 48.50 49.25 48.50 48.75 48.50 212,764
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 227.60 469.28 -0.04 4.65 1.10 10.43 2.27 58.25 - 40.50

Alliance Pharma Key Figures

(at previous day's close)
Market Cap.227.60m
Shares In Issue469.28m
Prev. Close49.50
PE Ratio10.43 
Dividend Yield2.27%
EPS - basic4.65p
Dividend PS1.10p
Dividend Cover4.23 
Cash Flow PS1.70p
Return On Equity (ROE)7.81%
Operating Margin31.40%
PEG Factor0.22 
EPS Growth Rate46.69%
Dividends PS Growth Rate10.00%
Net Debt126.52m
Gross Gearing44.41%
Quick Assets16.74m
Net Working Capital-2.11m
Intangibles / Fixed Assets99.01%
Turnover PS10.30p
Pre-Tax Profit PS3.24p
Retained Profit PS2.14p
Cash PS0.69p
Net Cash PS-6.08p
Net Tangible Asset Value PS *-20.78p
Net Asset Value PS34.62p
Spread0.75 (1.52%) 

Alliance Pharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week51.0046.00
4 weeks51.0044.50
12 weeks51.0040.50
1 year58.2540.50

Share Price Chart (5 years)

Alliance Pharma Historic Returns

Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week48.000.501.0448.150.4549.06
4 weeks45.253.257.1846.360.5546.62
12 weeks48.000.501.0445.770.6845.66
26 weeks48.63-0.13-0.2646.700.5946.41
1 year55.75-7.25-13.0049.010.5447.86
3 years35.3813.1337.1040.760.3543.05
5 years28.7519.7568.7036.850.3039.25

Alliance Pharma Key Management Ratios

Alliance Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio309.02 
PE Ratio10.43 
Tobin's Q Ratio 1.14 
Tobin's Q Ratio (excl. intangibles)8.88 
Dividend Yield2.27%
Market-to-Book Ratio1.40 
Price-to-Pre-Tax Profit PS14.99 
Price-to-Retained Profit PS22.65 
Price-to-Cash Flow PS28.54 
Price-to-Sales PS4.71 
Price-to-Net Tangible Asset Value PS-2.33 
Price-to-Cash PS70.49 
Net Working Capital PS-0.45 
Price Pct to Working Capital PS-108.07%
Earnings Yield9.59%
Average PE9.70 
Years in average5 
PE to PE average107.54%

Alliance Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio37.63%
Debt-to-Equity Ratio0.60 
Debt-to-Equity Ratio (excl. Intgbl)-1.01 
Debt-to-Equity Market Value0.43 
Net Gearing43.30%
Net Gearing (excl. Intangibles)392.33%
Gross Gearing44.41%
Gross Gearing (excl. Intangibles)402.34%
Gearing Under 1 Year10.87%
Gearing Under 1 Year (excl. Intgbl)98.47%
(Liquidity Ratios)
Net Working Capital to Total Assets-0.72%
Current Ratio0.93 
Quick Ratio (Acid Test)0.53 
Liquidity Ratio0.10 
Cash & Equiv/Current Assets10.89%
(Solvency Ratios)
Enterprise Value322.37m
CFO/Attributable Profit0.63 
Total Debt/Equity Market Value0.57 
Total Debt/Sales2.68 
Total Debt/Pre-Tax Profit8.55 
Total Debt129.75m
Total Debt/Net Current Assets-61.61%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth6.77%
5 yr Compound Earnings Growth5.14%
10 yr Compound Earnings Growth30.69%
Earn drops > 5% in 10yrs5 
Beta (60-Mnth)Beta (36-Mnth)
Alpha (60-Mnth)Alpha (36-Mnth)

Alliance Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)5.83%
Return On Assets (ROA)6.35%
Net Profit Margin26.25%
Assets Turnover0.24 
Return On Equity (ROE)7.81%
Return On Investment (ROI)7.11%
Dividend Payout Ratio23.66%
Plowback Ratio76.34%
Growth from Plowback Ratio8.31%
Net Income Of Revenues20.79%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.41 
Fixed Assets Turnover0.27 
Current Assets Turnover2.06 
Net Working Capital Turnover 
Inventory Turnover5.14 
(Other Operating Ratios)
Total Assets-to-Sales4.14 
Debt Collection Period88.67Days

Alliance Pharma Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
07 Apr 2016FinalGBX0.7412/31/201412/31/201506/16/201606/17/201607/13/20161.10
09 Sep 2015InterimGBX0.3612/31/201412/31/201512/24/201512/29/201501/14/2016-
25 Mar 2015FinalGBX0.6712/31/201312/31/201406/18/201506/19/201507/15/20151.00
10 Sep 2014InterimGBX0.3312/31/201312/31/201412/03/201412/05/201401/15/2015-
26 Mar 2014FinalGBX0.6112/31/201212/31/201306/11/201406/13/201407/10/20140.91
11 Sep 2013InterimGBX0.3012/31/201212/31/201312/04/201312/06/201301/15/2014-
21 Mar 2013FinalGBX0.5512/31/201112/31/201206/12/201306/14/201307/11/20130.83
12 Sep 2012InterimGBX0.2812/31/201112/31/201212/05/201212/07/201201/15/2013-
22 Mar 2012FinalGBX0.5012/31/201012/31/201106/13/201206/15/201207/12/20120.75
07 Sep 2011InterimGBX0.2512/31/201012/31/201111/30/201112/02/201101/13/2012-
23 Mar 2011FinalGBX0.4012/31/200912/31/201006/15/201106/17/201107/14/20110.57
08 Sep 2010InterimGBX0.1712/31/200912/31/201012/01/201012/03/201001/14/2011-
24 Mar 2010FinalGBX0.2312/31/200812/31/200906/16/201006/18/201007/15/20100.30
09 Sep 2009InterimGBX0.0712/30/200806/30/200912/02/200912/04/200901/15/2010-

Alliance Pharma Fundamentals

 31 Dec 2012 (GBP)31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)
pre tax profit10.8124.08%12.0126.39%10.1623.33%15.1831.40%m
attributable profit8.6919.36%9.5821.06%8.3919.26%12.6926.25%m
retained profit6.8915.34%7.5416.58%5.9913.75%10.0520.79%m
eps - basic3.61 3.82 3.17 4.65 
eps - diluted3.40 3.68 3.16 4.55 
dividends per share0.83 0.91 1.00 1.10 

Alliance Pharma Balance Sheet

 31 Dec 2012 (GBP)31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)
 31 Dec 2012 (GBP)31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)
fixed assets fixed assets0.560.56%0.590.55%0.400.37%1.010.35%m
intangibles intangibles79.8979.39%89.0683.24%88.8882.39%259.9488.96%m
fixed investments fixed investments--%0.440.41%1.271.18%1.590.54%m
current assets - other current assets - other--%--%--%--%m
stocks stocks5.395.36%5.475.11%5.915.48%12.914.42%m
debtors debtors10.1510.08%10.549.85%9.989.25%13.514.62%m
cash & securities cash & securities4.634.61%0.890.83%1.431.33%3.231.11%m
creditors - short creditors - short22.0521.91%14.9513.97%11.4210.58%31.7610.87%m
creditors - long creditors - long26.7326.57%27.3725.59%25.6723.80%98.0033.54%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves51.8551.53%64.6760.44%70.7865.62%162.4455.59%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Alliance Pharma Cash Flow Statement

31 Dec 2012 (GBP)31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)
Operating CF12.4410.0311.427.98m
Pre-Financing CF-0.560.128.06-126.39m
Retained CF3.53-5.802.432.09m

Alliance Pharma Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Numis Securities LimitedMarket Maker(MMF)Broker/DealerNUMSRAZHGB2LBIC
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V:us D:20160828 22:31:57